BRYHALI
Google image searchProduct monograph
Active ingredient
halobetasol propionate, 0.01 %/W/W
DIN: 02506262
Dosage form(s): LOTION
Route(s) of administration: TOPICAL
Schedule: Prescription
Company: BAUSCH HEALTH, CANADA INC.
Date: 06-AUG-2021
ATC:
- D07 — CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS (ATC, ATC/DDD, )
- D07A — CORTICOSTEROIDS, PLAIN (ATC, ATC/DDD)
- D07AC — Corticosteroids, potent (group III) (ATC, ATC/DDD)
- D07AC21 — ULOBETASOL (ATC/DDD)
Reference brand drug: Ultravate
